FDA increasingly halting human trials as companies pursue risky, cutting-edge drugs

Hasan

New member
FDA increasingly halting human trials as companies pursue risky, cutting-edge drugs Agency places more holds on trials to protect patients, ensure studies are designed properly, Wall Street Journal review finds
 
Üst